These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1820093)

  • 1. The soluble interleukin-2 receptor as a marker for human neoplasia and immune status.
    Zerler B
    Cancer Cells; 1991 Dec; 3(12):471-9. PubMed ID: 1820093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms.
    Bodey B; Psenko V; Lipsey AL; Kaiser HE
    Anticancer Res; 1996; 16(1):219-24. PubMed ID: 8615612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
    Dejica D
    Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice.
    Wasik MA; Sioutos N; Tuttle M; Butmarc JR; Kaplan WD; Kadin ME
    Am J Pathol; 1994 May; 144(5):1089-97. PubMed ID: 8178932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of soluble interleukin-2 receptor in multiple myeloma].
    Akimoto Y; Ishiyama T; Ueno H; Hino K; Tomoyasu S; Tsuruoka N
    Rinsho Ketsueki; 1995 Nov; 36(11):1247-51. PubMed ID: 8691563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
    Shaarawy M; Darwish NA; Abdel-Aziz O
    J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of tumor necrosis factor and soluble interleukin 2 receptor as markers of disease activity and prognosis in childhood leukemia and lymphoma.
    Kalmanti M; Karamolengou K; Dimitriou H; Tosca A; Vlachonikolis I; Peraki M; Georgoulias V; Kalmantis T
    Int J Hematol; 1993 Apr; 57(2):147-52. PubMed ID: 8494993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti asialoglycoprotein receptor antibodies and soluble interleukin-2 receptor levels as marker for inflammation in autoimmune hepatitis.
    Dejica D; Treichel U; Pár A; Chira O; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1997 Jan; 35(1):15-21. PubMed ID: 9123953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma.
    Ihn H; Sato S; Fujimoto M; Kikuchi K; Takehara K
    Br J Dermatol; 1996 May; 134(5):843-7. PubMed ID: 8736323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentration of the soluble interleukin-2 receptor for monitoring acute graft-versus-host disease.
    Miyamoto T; Akashi K; Hayashi S; Gondo H; Murakawa M; Tanimoto K; Harada M; Niho Y
    Bone Marrow Transplant; 1996 Feb; 17(2):185-90. PubMed ID: 8640164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The soluble IL-2 receptor in malignant hemopathies].
    Rupoli S; Montillo M; Salvi A; Brianzoni MF; Centurioni R; Cinciripini A; Paoletti P; Recchioni A; Leoni P
    Recenti Prog Med; 1992 Oct; 83(10):546-51. PubMed ID: 1462037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum soluble IL-2 receptor as a reliable and noninvasive marker of disease activity in patients with hairy cell leukemia.
    Chrobák L; Podzimek K; Plísková L; Kerekes Z; Zák P; Voglová J; Spacek J; Palicka V
    Neoplasma; 1996; 43(5):321-5. PubMed ID: 8996552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble interleukin-2 receptor and soluble CD8 molecules in cerebrospinal fluid and serum of patients with multiple sclerosis.
    Carrieri PB; Soscia E; Iacovitti B; Pellicano M; D'Antonio A; Provitera V; Perrella O
    Eur Cytokine Netw; 1992; 3(5):495-8. PubMed ID: 1477299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma soluble interleukin-2 receptor (sIL-2R) levels in patients with acute leukemia.
    Moon Y; Kim Y; Kim M; Lim J; Kang CS; Kim WI; Shim SI; Chung NG; Park YH; Min WS; Han K
    Ann Clin Lab Sci; 2004; 34(4):410-5. PubMed ID: 15648782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between serum levels of soluble interleukin-2 receptor and various disease parameters in patients with squamous cell carcinoma of the esophagus.
    Oka M; Hazama S; Takahashi M; Yamamoto K; Abe T; Yoshino S; Hayashi H; Tangoku A
    Hepatogastroenterology; 1999; 46(28):2254-9. PubMed ID: 10521976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical significance of the measurement of serum soluble interleukin-2 receptors in various diseases].
    Sugimoto H; Hashimoto N; Suzuki S; Gejyo F
    Rinsho Byori; 1996 Feb; 44(2):176-82. PubMed ID: 8851203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].
    Shimomura Y; Tsurumi H; Sawada M; Yamada T; Hara T; Fukuno K; Goto H; Moriwaki H
    Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble adhesion molecules and interleukin-2 receptor concentrations in patients with autoimmune chronic hepatitis.
    Simpson KJ; Jones AL; Forbes Howie A; Hayes PC
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):455-60. PubMed ID: 7542148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of the measurement of serum soluble IL-2 receptor alpha chain levels in clinical monitoring of non-Hodgkin lymphoma].
    Setoyama Y; Imai J; Ishikawa T; Sakaida H; Takaori-Kondo A; Kawamata S; Uchiyama T
    Rinsho Byori; 1994 Aug; 42(8):834-42. PubMed ID: 7933620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.